Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neeraj Agarwal

Showing results (1-10 of 697) with videos related to

Pageof 70
Sort By:
JAMA|January 7, 2010
Hormonal therapy for prostate cancer in men with heart diseaseNeeraj Agarwal
The Journal of Urology|July 28, 2011
Editorial commentNeeraj Agarwal
Investigative Ophthalmology & Visual Science|December 5, 2013
RGC-5 cellsNeeraj Agarwal
Critical Reviews in Oncogenesis|April 2, 2018
The Role of Transcription Factor YY1 in the Biology of CancerNeeraj Agarwal, Dan Theodorescu
Cancer Treatment and Research Communications|August 22, 2020
Improvement in overall survival with Apalutamide, Darolutamide and Enzalutamide in patients with non-metastatic castration-resistant prostate cancerUmang Swami, Neeraj Agarwal
Hematology/Oncology Clinics of North America|November 6, 2013
Management of hormone-sensitive metastatic prostate cancerNeeraj Agarwal, Maha Hussain
Drugs|June 23, 2009
Management of bladder cancer: current and emerging strategiesNeeraj Agarwal, Maha Hussain
The Lancet. Oncology|October 3, 2021
Drug development in metastatic prostate cancer: lessons from ACISUmang Swami, Neeraj Agarwal
The Journal of Urology|September 7, 2018
Editorial CommentAbhishek Tripathi, Neeraj Agarwal
Oncology (Williston Park, N.Y.)|September 26, 2009
Optimal treatment in the postorchiectomy management of clinical stage I seminomaNeeraj Agarwal, Julia Batten
Pageof 70

Showing results (1-10 of 697) with videos related to

Sort By:
Pageof 70
JAMA|January 7, 2010
Hormonal therapy for prostate cancer in men with heart diseaseNeeraj Agarwal
The Journal of Urology|July 28, 2011
Editorial commentNeeraj Agarwal
Investigative Ophthalmology & Visual Science|December 5, 2013
RGC-5 cellsNeeraj Agarwal
Critical Reviews in Oncogenesis|April 2, 2018
The Role of Transcription Factor YY1 in the Biology of CancerNeeraj Agarwal, Dan Theodorescu
Cancer Treatment and Research Communications|August 22, 2020
Improvement in overall survival with Apalutamide, Darolutamide and Enzalutamide in patients with non-metastatic castration-resistant prostate cancerUmang Swami, Neeraj Agarwal
Hematology/Oncology Clinics of North America|November 6, 2013
Management of hormone-sensitive metastatic prostate cancerNeeraj Agarwal, Maha Hussain
Drugs|June 23, 2009
Management of bladder cancer: current and emerging strategiesNeeraj Agarwal, Maha Hussain
The Lancet. Oncology|October 3, 2021
Drug development in metastatic prostate cancer: lessons from ACISUmang Swami, Neeraj Agarwal
The Journal of Urology|September 7, 2018
Editorial CommentAbhishek Tripathi, Neeraj Agarwal
Oncology (Williston Park, N.Y.)|September 26, 2009
Optimal treatment in the postorchiectomy management of clinical stage I seminomaNeeraj Agarwal, Julia Batten
Pageof 70